omeprazole and famotidine

omeprazole has been researched along with famotidine in 204 studies

Research

Studies (204)

TimeframeStudies, this research(%)All Research%
pre-199013 (6.37)18.7374
1990's89 (43.63)18.2507
2000's71 (34.80)29.6817
2010's25 (12.25)24.3611
2020's6 (2.94)2.80

Authors

AuthorsStudies
Kanamaru, M; Nakashima, M1
Ogawa, N1
Arisawa, T; Asai, J; Goto, H; Hase, S; Suzuki, T; Tsukamoto, Y1
Halabi, A; Kirch, W1
Alcón, A; Bisbe, E; Castaño, J; Escolano, F; López, R1
Annibale, B; Cassetta, MR; Delle Fave, G; Franceschi, M; Quatrini, M; Torsoli, A1
Babu, S; Chaubal, C; Kumar, TR; Naidu, MU; Prasad, R; Reddy, DN; Shobha, JC; Subhash, S1
Gardner, JD; Jensen, RT; Maton, PN; Metz, DC; Norton, JA; Pisegna, JR; Slimak, GG1
Grymbowski, T; Hennig, U; Hotz, J; Kleinert, R; Schwarz, JA1
Battaglia, G; Cammelli, F; Lualdi, M; Pesci, M; Seveso, M; Vimercati, C1
Guram, M; Holt, S; Howden, CW1
Fennerty, MB; Sampliner, RE1
Bräuer, U; Kromer, W; Postius, S1
Inatomi, N; Nagaya, H; Satoh, H1
Inatomi, N; Nagaya, H; Satoh, H; Shino, A; Takami, K1
Bianchi-Porro, G; Bonavina, L; Pace, F; Peracchia, A; Sangaletti, O; Termini, R; Vigneri, S1
Horikoshi, T; Kobayashi, S; Kusano, M; Matsuzaki, T; Nishioka, T; Ohwada, T; Sekiguchi, T; Sugiyama, M; Toki, M1
Amoruso, A; Barone, M; Di Leo, A; Francavilla, A; Ingrosso, M; Makowka, L; Panella, C; Polimeno, L; Starzl, TE1
Davis, MA; Decktor, DL; Kellner, AT; Pendleton, RG1
De Natale, F; De Natale, G; Marino, A1
Gardner, JD; Jensen, RT; Maton, PN1
Fabian, MA; Fabri, PJ; Gower, WR; Knierim, TH1
Itoh, H; Ono, T; Shibayama, F; Tomoi, M; Ueda, S1
Cook, PG; Mangel, AW; Pendleton, RG; Shepherd-Rose, A1
Mahachai, V; Thomson, AB1
Asano, K; Haga, K; Maruyama, Y; Osuga, K1
Gugler, R2
Asaki, S; Hongo, M; Motojima, T; Ohara, S; Ohara, T; Sato, A; Sato, H; Shibuya, D; Tamura, T; Yamaguchi, N1
Burget, DW; Howden, CW; Hunt, RH; Jones, DB1
Andrews, P; Bae, H; Borody, TJ; Brandl, S; Fracchia, G; Shortis, NP1
Akuzawa, S; Ito, H; Kamato, T; Kobayashi-Uchida, A; Nagakura, Y; Nishida, A; Shishido, T; Takinami, Y; Yamano, M; Yuki, H1
Carrasquer, G; Geng, Z; Rehm, WS; Schilb, TP; Schwartz, M1
Goto, H; Hamajima, E; Hoshino, H; Ozawa, T; Sugiyama, S; Tsukamoto, Y1
Fukuda, M; Higashi, T; Imaizumi, T; Kawano, S; Miura, N; Miyajima, K; Mukuda, T; Noguchi, M; Tatsumi, T; Tsuji, S1
Ashida, K; Katsu, K; Miyoshi, H; Sakaguchi, M; Umegaki, E1
Motoo, Y; Okai, T; Sawabu, N; Songür, Y; Watanabe, H1
Fukuchi, S; Hashimoto, M; Hoshihara, Y; Iguchi, D; Kimura, T; Sugawara, K; Takemoto, T; Tanaka, T; Yamamoto, T2
Asagoe, K; Dekigai, H; Kusaka, S; Maeda, S; Matsumoto, M; Mizuno, M; Murakami, M; Saita, H; Seki, M; Takahashi, Y1
Hanson, DG; Kahrilas, PJ; Kamel, PL1
Maculotti, L; Pradella, P1
Hoshino, E; Miki, K; Umeda, N1
Asaka, M; Hokari, K; Takeda, H1
Echevarria, V; Espachs, P; Garcia, M; Rincón, R; Vidal, F; Vila, P1
Chiba, T; Chihara, K; Kinoshita, Y; Yamashita, Y1
Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, J; Sullivan, TJ1
Dominguez, HL; Freston, JW1
Goh, KL; Parasakthi, N1
Chijiiwa, Y; Maruoka, A; Nawata, H; Tanaka, M1
Arizón Deza, P; García Tenorio, A; Gonzalo Til, A; Manero Ruiz, I; Mur Lalueza, MJ; Pascual Parrilla, MS1
Fujihara, A; Kamato, T; Miyata, K; Nishida, A; Takeda, M; Yuki, H1
Fujimoto, K; Iwakiri, R; Koyama, T; Mizuguchi, M; Ohyama, T; Sakata, H; Tanaka, J; Tokunaga, O1
Besancon, M; Helander, H; Sachs, G; Scott, DR1
Akuzawa, S; Ito, H; Kamato, T; Kobayashi, A; Miyata, K; Nagakura, Y; Nishida, A; Takinami, Y; Yamano, M; Yuki, H1
Meiser, BM; Muschiol, F; Nollert, G; Pfeiffer, M; Reichart, B; Reichenspurner, H; Uberfuhr, P; Vetter, HO; Wagner, F1
Blanloeil, Y; Boulay, K; Bourveau, M; Geay, G; Malinovsky, JM1
Bhasin, DK; Khosla, PP; Sachdev, A; Saha, N; Sankaranahyanan, A; Sharma, PL; Singh, K1
Davis, RL; Egli, D; Hashimoto, F1
Busam, J; Garbe, WE1
Colin, R; Cortot, A; Ducrotté, P; Elouaer-Blanc, L; Guillemot, F; Hirschauer, C; Hochain, P; Michel, P; Petit, A; Thorel, JM1
Dasarathy, S; Misra, SC; Sharma, MP1
Haruma, K; Kajiyama, G; Sachs, G; Sumii, K; Sumii, M; Takehara, Y; Tari, A; Walsh, JH; Wu, V; Yamamoto, G1
Sakaki, N; Takemoto, T1
Carrasquer, G; Rehm, WS; Schwartz, M; Wu, X; Zhang, JY1
Arakawa, T; Higuchi, K; Kobayashi, K; Oshitani, N; Yamada, T1
Annibale, B; Cassetta, MR; Corleto, V; D'Ambra, G; Delle Fave, G; Ferrua, B; Saggioro, A1
Aono, T1
Agostini, H; Lemaire, M; Poynard, T1
Gomez, G; Greeley, GH; Padilla, L; Sundler, F; Tarasova, N; Thompson, JC; Townsend, CM; Udupi, V1
Inada, I; Satoh, H1
Chuah, SY; Goh, KL; Lo, YL; Navaratnam, P; Peh, SC; Rahman, NA; Wong, NW1
Chakrabarti, A; Goenka, MK; Gupta, O; Kochhar, R; Kumar, A; Mehta, SK; Talwar, P1
Guslandi, M1
Boland, CR; Delbarre, SG; Kraus, E; Yoshimura, K1
Asano, S; Inatomi, N; Murakami, I; Nagaya, H; Satoh, H; Yukishige, K1
Asano, S; Inada, I; Inatomi, N; Murakami, I; Satoh, H1
Chen, TL; Hsu, HW; Huang, CL; Lin, CJ1
Berstad, A; Hatlebakk, JG1
Altschul, M; Cummings, JF; Dykes, NL; Mauldin, EA; Reubi, JC; Simpson, KW1
Itoh, T; Kamisaki, Y; Kawasaki, H; Kishimoto, Y; Kitano, M; Nakamoto, K; Wada, K1
Moayyedi, P1
Florholmen, J; Løvhaug, N; Støa-Birketvedt, G; Vonen, B1
Hibi, T; Ishii, H; Iwai, N; Miyayama, A; Mori, M; Oonuki, M; Suzuki, H; Suzuki, M; Tsunematsu, N1
Haga, Y; Nakamura, Y; Nakatsura, T; Ogawa, M; Sameshima, H; Shibata, Y; Tanimura, M1
Brown, KL; Fisher, RS; Knight, LC; Maurer, AH; Miller, MA; Parkman, HP; Trate, DM; Urbain, JL1
Goral, V; Inalöz, SS; Sari, I1
Alm, C; Grahnén, A; Hedenström, H; Kraft, M1
Chan, CK; Cheung, E; Ching, TY; Chu, KM; Kong, Y; Kou, M; Kumana, CR; Lam, SK; Seto, WH1
Arai, H; Inoie, M; Marubuchi, S1
Kanayama, S1
Armstrong, D; Lad, R1
Saika, M; Senba, E; Ueyama, T1
Jacoby, EB; Porter, KB1
Fujimoto, S; Fujita, T; Kodama, Y; Kutsumi, H; Matsuura, M; Nishimura, K; Sekimoto, I; Soga, T; Yoshida, S1
Sugano, K1
Itoh, M; Joh, T; Kurokawa, T; Sasakii, M; Seno, K; Tsuchida, K; Yokoyama, Y1
Berstad, A; Hatlebakk, JG; Olafsson, S; Wilhelmsen, I1
Brandstätter, G; Dragosics, B; Gschwantler, M; Hentschel, E; Hirschl, AM; Klimpfinger, M; Oberhuber, G; Pasching, E; Schütze, K; Weiss, W; Wimmer, M; Wurzer, H1
Abidin, ZU; Ivashkin, VT; Okhlobystin, AV; Sheptulin, AA; Trukhmanov, AS1
Dave, B; Rubin, W1
Martin, P; McKeand, W; Ohning, G; Paul, J; Pisegna, JR; Walsh, JH1
Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M1
Aibe, T; Eto, S; Fujisaki, T; Iida, T; Matsuoka, H; Mine, S; Morimoto, I; Tabata, T; Tanaka, Y; Yamada, S1
Fujita, N; Kassai, K; Kondo, M; Naito, Y; Tanaka, Y; Yoshida, N; Yoshikawa, T1
Endo, M; Sugihara, K1
Mashiba, H; Matsumura, N; Okamoto, S; Sasaki, N; Taniyama, K; Uemura, N; Yamaguchi, S; Yamamoto, S1
Arbak, S; Ayanoğlu-Dülger, G; Hürdağ, C; Paskaloğlu, K; Sener-Muratoğlu, G1
Ivashkina, TG; Kulikov, AN; Malov, IuS1
Miehsler, W; Oberhuber, T; Püspök, A; Vogelsang, H1
Changchien, CS; Chen, JJ; Hsu, CC; Hu, TH; Lu, SN1
Golochalova, TV; Gorbakov, VV; Makarov, IuS; Mironenko, DA; Rakov, AL1
Akcay, MF; Banoglu, ZN; Büyükokuroglu, ME; Demirezer, LO; Gepdiremen, A; Göçer, F; Süleyman, H1
Mutoh, H; Sugano, K1
Ahmed, F; Castell, DO; Katz, PO; Korn, S; Tutuian, R1
Furuta, T; Hanai, H; Ishizaki, T; Kajimura, M; Ohashi, K; Shirai, N; Xiao, F1
Aoyagi, K; Esaki, M; Fujishima, M; Kuwano, Y; Matsumoto, T; Shimizu, M1
Matsuno, K; Okabe, S; Tomita, K1
Matsuoka, T; Miyazawa, K; Mizokami, Y; Nakamura, H; Narushima, K; Otsubo, T; Shiraishi, T1
Muravtseva, OV; Vakhrushev, IaM2
Abe, K; Adachi, K; Hamamoto, N; Ishihara, S; Kawashima, K; Kawauchi, H; Kinoshita, Y; Mak, R; Moritani, M; Oshima, N; Sato, H1
Shcherbynina, MB1
Iishi, H; Ikeda, M; Kanda, T; Kaneko, A; Kashio, S; Kawano, S; Kubo, M; Masuda, E; Murata, H; Noguchi, M; Sato, T; Tatsuta, M; Tsuji, S; Yoshihara, H1
Lam, EK; Lo, KY; Loo, CK; Mak, SK; Tong, GM; Wong, AK; Wong, AM; Wong, PN1
Fukao, K; Homma, M; Itagaki, F; Kohda, Y; Yuzawa, K1
Grinevich, VB; Sablin, OA; Uspenskiĭ, IuL1
Adachi, K; Fujishiro, H; Kinoshita, Y; Komazawa, Y; Mihara, T1
Chan, CC; Chen, TK; Lee, CL; Liao, CC; Liu, CC; Tu, TC; Wu, CH1
Abe, Y; Chiguchi, G; Inamori, M; Kawamura, H; Kikuchi, T; Kirikoshi, H; Kobayashi, N; Muramatsu, K; Nakajima, A; Sakaguchi, T; Sekihara, H; Takamura, T; Togawa, J; Ueno, N1
Ishihara, S; Kinoshita, Y1
Akturk, Z; Ekinci, H; Muftuoglu, T; Peker, O; Topaloglu, U; Unalmiser, S1
Habu, Y; Hayakumo, T; Kawai, K; Shio, S; Yoshino, T1
Demir, N; Demir, Y; Nadaroğlu, H1
Iakovenko, AV; Iakovenko, EP; Ivanov, AN1
Osipenko, MF; Venzhina, IuIu1
Abe, Y; Chiguchi, G; Inamori, M; Kawamura, H; Kikuchi, T; Kirikoshi, H; Kobayashi, N; Muramatsu, K; Nakajima, A; Sakaguchi, T; Shimamura, T; Takamura, T; Togawa, J; Ueno, N1
Coursol, CJ; Sanzari, SE1
Allen, DG; Bersenas, AM; Conlon, PD; Mathews, KA1
Scarpignato, C1
Furuta, T; Hishida, A; Ishizaki, T; Kajimura, M; Nakamura, A; Ohashi, K; Shirai, N; Sugimoto, M1
Fujita, F; Itoh, K; Itoh, M; Joh, T; Kataoka, H; Kubota, E; Mori, Y; Nakao, H; Ogasawara, N; Ohara, H; Oshima, T; Sasaki, M; Sobue, S; Tanida, S; Togawa, S; Wada, T; Yamada, T1
Arakawa, T; Chono, S; Fujiwara, Y; Higuchi, K; Kitada, K; Kobayashi, K; Nakagawa, K; Nebiki, H; Oshitani, N; Satoh, H; Tominaga, K; Uno, H; Watanabe, T1
Futagami, S; Hiratsuka, T; Kusunoki, M; Miyake, K; Nakajima, A; Nishigaki, H; Sakamoto, C; Shinji, Y; Suzuki, K; Tatsuguchi, A; Tsukui, T; Ueki, N; Wada, K; Yoshino, S1
Aoki, R; Chayama, K; Dongmei, Q; Hamada, H; Haruma, K; Hata, J; Hidaka, T; Kamada, T; Kido, S; Komoto, K; Kusunoki, H; Nishida, T; Ogoshi, H; Sanuki, E; Sumii, K; Sumioka, M; Tanimoto, T; Todo, H1
Aoki, K; Ishida, H; Katsumi, N; Miura, M; Morita, Y; Morozumi, K; Nakamura, K; Takahashi, S; Tauchi, M; Toki, M; Yamaguchi, Y1
Furuta, T; Hishida, A; Kajimura, M; Nakamura, A; Okudaira, K; Shirai, N; Sugimoto, M1
Adachi, K; Amano, Y; Fujishiro, H; Furuta, K; Hashimoto, T; Hattori, S; Ishihara, S; Kinoshita, Y; Komazawa, Y; Mihara, T1
de la Fuente, SG; Fujino, K; Mantyh, CR; Takahashi, T; Takami, Y1
Evseev, MA; Gostishchev, VK1
Iida, T; Kishikawa, H; Mine, S; Tabata, T; Tanaka, Y1
Hashimoto, H; Hirota, K; Kudo, M; Kushikata, T1
Bektaş, M; Cetinkaya, H; Ozden, A; Soykan, I; Törüner, M1
Amagase, K; Fujimura, T; Kotani, T; Okabe, S; Takeuchi, K1
Furuta, T; Miura, S; Okudaira, K; Shirai, N; Sugimoto, M1
Bozkurt, B; Demirkan, K; Kalyoncu, AF; Karakaya, G1
Gon, S; Irie, Y; Takahashi, M1
Cheon, JH; Choi, KD; Jung, HC; Kim, JS; Kim, SG; Song, IS; Ye, BD1
Horikawa, Y; Itoh, H; Jin, M; Komatsu, K; Konishi, N; Matsuhashi, T; Odashima, M; Ohba, R; Otaka, M; Wada, I; Watanabe, S1
Furuta, T; Hishida, A; Ikuma, M; Ishizaki, T; Shirai, N; Sugimoto, M1
Esplugues, JV; Martí-Cabrera, M; Ponce, J1
Ikawa, K; Inoue, M; Kuroiwa, T; Morikawa, N; Moriwaki, M; Shimatani, T; Tazuma, S; Xu, J1
Allgood, LD; Grender, JM; Miner, PB1
Malur, PR; Patil, PA; Rao, KS1
Beketov, AS; Belousov, DIu; Belousov, IuB; Karpov, OI1
Fändriks, L; Lönroth, H; Pettersson, A; Vakil, N1
Adachi, K; Fujimoto, K; Fujimura, Y; Fujisawa, T; Fuyuno, S; Haruma, K; Hori, K; Kido, S; Kin, Y; Kinoshita, Y; Kobori, M; Kusaka, M; Kusunoki, H; Matsunobu, A; Miwa, H; Nakamura, Y; Ono, N; Oza, N; Sugimoto, K; Tano, N; Tomita, T; Watanabe, Y; Yamauchi, R; Yuki, M1
Evseev, MA; Golovin, RA; Ivakhov, GB1
Amagase, K; Kato, S; Ochi, A; Sugihara, T; Takeuchi, K1
Caínzos-Romero, T; Fernández-Fernández, FJ; Ferreira, L; Sesma, P1
Caínzos-Romero, T; Fernández-Fernández, FJ; Ferreira-González, L; Sesma, P1
Hiraishi, H; Kanke, K; Maeda, M; Sasai, T; Shimada, T1
Aihara, E; Demitrack, ES; Kenny, S; Montrose, MH; Varro, A1
Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B1
McColl, KE1
Ariyama, S; Kani, K; Kato, S; Kawashima, J; Ohno, S; Sakurada, T; Takabayashi, H; Yakabi, K1
Hashimoto, E; Izuhara, C; Kaneko, S; Takayama, S; Takeuchi, K; Yamada, N; Yamanaka, S1
Fukui, H; Hori, K; Kim, Y; Kondo, T; Matsumoto, T; Miwa, H; Morita, T; Okugawa, T; Oshima, T; Sakurai, J; Tanaka, J; Tomita, T; Toyoshima, F; Watari, J; Yamasaki, T1
Akiyama, J; Araki, A; Fujimoto, K; Fujimura, T; Fujioka, Y; Habu, Y; Harada, R; Haruma, K; Inoue, K; Kinoshita, Y; Kusaka, M; Mabe, K; Miwa, H; Miwa, J; Nagahara, A; Nagami, H; Oumi, T; Sakurai, K; Satoh, K; Shigeto, N; Suzuki, J; Suzuki, T; Tano, N1
Hauso, Ø; Waldum, HL1
Endo, T; Fukui, K; Hibi, K; Himeno, H; Kimura, K; Morita, S; Sugano, T; Tsukahara, K; Umemura, S; Yano, H1
Czimmer, J; Mózsik, G; Szabó, IL; Szolcsányi, J1
Horiuchi, H1
Abramowitz, Y; Arbel, Y; Banai, S; Berliner, S; Birati, EY; Deutsch, V; Finkelstein, A; Halkin, A; Herz, I; Keren, G; Kletzel, H1
Chan, HH; Chen, WC; Cheng, JS; Chiang, PH; Lai, KH; Li, YD; Tsai, TJ; Tsai, WL; Tsay, FW; Wang, EM1
Chang, YW; Choi, MG; Chun, HJ; Han, SW; Jeong, HY; Jung, HC; Jung, HY; Jung, JT; Kim, EH; Kim, HS; Kim, HY; Kim, JG; Lee, DH; Lee, OJ; Lee, ST; Lee, SW; Lee, YC; Park, JJ; Park, SH; Seol, SY; Youn, SJ1
Brand, M; Davidson, G; Messenger, K; Odunayo, A; Papich, MG; Parkinson, S; Peters, E; Reed, A; Tolbert, K1
Boulton, DW; Ren, S1
Anderson, K; Cuvin, J; Kotecha, M; Namour, F; Qin, AR; Scott, B; Sharma, S; Xin, Y; Zheng, H1
Chen, WC; Cheng, JS; Chuah, SK; Hsu, PI; Kao, SS; Peng, NJ; Shie, CB; Tang, SY; Tsai, KF; Tsay, FW; Tseng, ZF1
Balaji, U; Chang, Y; Gu, J; Nelson, M; Odiase, E; Pan, Z; Souza, RF; Spechler, SJ; Zhang, Q; Zhang, X1
Fass, R; Ganocy, SJ; Kim, YD; Poels, KE; Shibli, F; Wang, J1
Fulkerson, CM; Moore, GE; Shaevitz, MH1
Galyon, G; Hecht, S; Odunayo, A; Price, J; Tolbert, MK1
D'Andrea, E; Desai, RJ; Feldman, WB; Lin, KJ; Liu, J; Pramod Umarje, S; Tesfaye, H; Wang, SV; Zabotka, LE1
Topliss, JG; Yoshida, F1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

16 review(s) available for omeprazole and famotidine

ArticleYear
[Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    La Clinica terapeutica, 1989, Apr-15, Volume: 129, Issue:1

    Topics: Antacids; Anti-Ulcer Agents; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Peptic Ulcer; Pirenzepine; Ranitidine; Thiazoles

1989
Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
    Gastroenterology clinics of North America, 1989, Volume: 18, Issue:4

    Topics: Cimetidine; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Nizatidine; Omeprazole; Parasympatholytics; Ranitidine; Thiazoles; Zollinger-Ellison Syndrome

1989
Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
    Clinical and investigative medicine. Medecine clinique et experimentale, 1987, Volume: 10, Issue:3

    Topics: Alprostadil; Antacids; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Enprostil; Famotidine; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Prostaglandins E, Synthetic; Ranitidine; Sucralfate; Thiazoles

1987
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    European journal of gastroenterology & hepatology, 1995, Volume: 7, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Time Factors; Wound Healing

1995
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Clinical pharmacokinetics, 1996, Volume: 31, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides

1996
[Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
    Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine

1999
Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 1999, Volume: 13, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Gastric Juice; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer

1999
[Duodenal ulcer].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 1

    Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Japan; Male; Omeprazole; Prognosis; Sex Factors; Time Factors

2002
[Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Japan; Lansoprazole; Markov Chains; Meta-Analysis as Topic; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Randomized Controlled Trials as Topic

2004
Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Esophagitis, Peptic; Famotidine; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Quality of Life

2005
[Concomitant dosing of a H2 receptor antagonist (H2RA) with a triple therapy increases the cure rate of Helicobacter pylori infection].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 11

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic

2005
Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.
    Journal of investigational allergology & clinical immunology, 2006, Volume: 16, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anaphylaxis; Anti-Ulcer Agents; Benzimidazoles; Famotidine; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Skin Tests

2006
[Safety of proton pump inhibitors].
    Medicina clinica, 2006, Nov-25, Volume: 127, Issue:20

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors

2006
[Strategy to manage low dose aspirin-induced gastrointestinal injury].
    Nihon rinsho. Japanese journal of clinical medicine, 2011, Volume: 69, Issue:2

    Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clopidogrel; Famotidine; Gastric Mucosa; Humans; Omeprazole; Peptic Ulcer; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Proton Pump Inhibitors; Ticlopidine

2011
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
    Current pharmaceutical design, 2013, Volume: 19, Issue:1

    Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine

2013
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

77 trial(s) available for omeprazole and famotidine

ArticleYear
[Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adolescent; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Famotidine; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Humans; Lansoprazole; Middle Aged; Omeprazole; Stomach Ulcer

1992
Cardiovascular effects of omeprazole and famotidine.
    Scandinavian journal of gastroenterology, 1992, Volume: 27, Issue:9

    Topics: Aged; Cardiac Output; Double-Blind Method; Dyspepsia; Famotidine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Omeprazole; Stroke Volume

1992
Effects of omeprazole, ranitidine, famotidine and placebo on gastric secretion in patients undergoing elective surgery.
    British journal of anaesthesia, 1992, Volume: 69, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Famotidine; Female; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pneumonia, Aspiration; Premedication; Ranitidine

1992
Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease.
    Alimentary pharmacology & therapeutics, 1992, Volume: 6, Issue:4

    Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Duodenal Ulcer; Evaluation Studies as Topic; Famotidine; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole

1992
Comparative study of omeprazole and famotidine in the treatment of duodenal ulcer.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 1992, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Aged; Double-Blind Method; Duodenal Ulcer; Famotidine; Female; Humans; Male; Middle Aged; Omeprazole; Smoking

1992
Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
    Gastroenterology, 1992, Volume: 102, Issue:3

    Topics: Adult; Aged; Cimetidine; Dose-Response Relationship, Drug; Duodenal Neoplasms; Famotidine; Female; Follow-Up Studies; Gastric Acid; Gastric Mucosa; Gastrinoma; Gastrins; Humans; Male; Middle Aged; Omeprazole; Pancreatic Neoplasms; Postoperative Period; Prospective Studies; Ranitidine; Sex Factors; Time Factors; Zollinger-Ellison Syndrome

1992
Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
    Alimentary pharmacology & therapeutics, 1992, Volume: 6, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Famotidine; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Recurrence

1992
[Comparative study of the effects of famotidine and omeprazole in the prevention of the aspiration of gastric contents syndrome in elective surgery].
    Minerva anestesiologica, 1992, Volume: 58, Issue:4

    Topics: Famotidine; Humans; Intraoperative Complications; Omeprazole; Pneumonia, Aspiration

1992
High-dose famotidine in the maintenance treatment of refractory esophagitis: results of a "medium-term" open study.
    The American journal of gastroenterology, 1991, Volume: 86, Issue:11

    Topics: Adult; Double-Blind Method; Esophagitis; Esophagoscopy; Famotidine; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Time Factors

1991
Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori.
    Gut, 1995, Volume: 37, Issue:4

    Topics: Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline

1995
Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
    Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Famotidine; Female; Fibroblast Growth Factor 2; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach; Stomach Ulcer

1995
Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Depression, Chemical; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Stomach Ulcer

1995
Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
    Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Famotidine; Female; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach Ulcer; Ultrasonography

1995
Effects of lansoprazole on mucosal regeneration in patients with gastric ulcers: evaluation using an electronic endoscope with a magnifying function.
    Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastric Mucosa; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Regeneration; Stomach Ulcer

1995
Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
    Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Ulcer Agents; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors

1995
[Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
    Minerva chirurgica, 1995, Volume: 50, Issue:3

    Topics: Duodenal Ulcer; Famotidine; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine

1995
Lansoprazole versus famotidine in symptomatic reflux esophagitis: a randomized, multicenter study.
    Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Anti-Ulcer Agents; Cross-Over Studies; Endoscopy, Digestive System; Esophagitis, Peptic; Famotidine; Female; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Retrospective Studies

1995
Acid aspiration prophylaxis in elective biliary surgery. A comparison of omeprazole and famotidine using manually aided gastric aspiration.
    Anaesthesia, 1994, Volume: 49, Issue:10

    Topics: Adult; Aged; Biliary Tract Surgical Procedures; Elective Surgical Procedures; Famotidine; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pneumonia, Aspiration; Premedication; Suction

1994
[Comparison of the effects between standard doses of H2-blocker (famotidine 20mg b.d.) and proton pump inhibitor (omeprazole 20mg o.d.) in the treatment of refractory reflux esophagitis by ambulatory 24-hr intra-gastroesophageal pH monitoring].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1994, Volume: 91, Issue:12

    Topics: Aged; Aged, 80 and over; Ambulatory Care; Esophagitis, Peptic; Esophagus; Famotidine; Female; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Physiologic; Omeprazole

1994
Primary and acquired resistance to clarithromycin among Helicobacter pylori strains in Malaysia.
    The American journal of gastroenterology, 1995, Volume: 90, Issue:3

    Topics: Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Microbial Sensitivity Tests; Omeprazole

1995
Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents.
    Transplantation proceedings, 1994, Volume: 26, Issue:5

    Topics: Administration, Oral; Aluminum Hydroxide; Animals; Antacids; Anti-Ulcer Agents; Antilymphocyte Serum; Azathioprine; Cimetidine; Cyclosporine; Drug Combinations; Famotidine; Female; Heart Transplantation; Humans; Intestinal Absorption; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pirenzepine; Prednisone; Rats; Rats, Inbred BN

1994
Effects of oral ranitidine, famotidine and omeprazole on gastric volume and pH at induction and recovery from general anaesthesia.
    British journal of anaesthesia, 1994, Volume: 73, Issue:4

    Topics: Administration, Oral; Adult; Aged; Anesthesia, General; Elective Surgical Procedures; Famotidine; Gastric Juice; Humans; Hydrogen-Ion Concentration; Middle Aged; Omeprazole; Pneumonia, Aspiration; Postoperative Complications; Preanesthetic Medication; Ranitidine

1994
Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    International journal of clinical pharmacology, therapy, and toxicology, 1993, Volume: 31, Issue:7

    Topics: Adult; Cimetidine; Drug Hypersensitivity; Dyspepsia; Famotidine; Female; Histamine; Histamine H2 Antagonists; Humans; India; Male; Middle Aged; Omeprazole; Ranitidine

1993
Omeprazole versus famotidine in the healing and relapse of duodenal ulcer.
    Alimentary pharmacology & therapeutics, 1993, Volume: 7, Issue:4

    Topics: Absenteeism; Adult; Analgesics; Antacids; Double-Blind Method; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pain; Recurrence; Wound Healing

1993
Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy.
    European journal of gastroenterology & hepatology, 1996, Volume: 8, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Treatment Outcome; Wound Healing

1996
Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole.
    Journal of clinical gastroenterology, 1996, Volume: 23, Issue:1

    Topics: Adult; Anti-Ulcer Agents; Candidiasis; Cimetidine; Duodenal Diseases; Duodenal Ulcer; Famotidine; Female; Gastric Acidity Determination; Humans; Male; Omeprazole; Prospective Studies

1996
Prophylaxis against acid aspiration in regional anesthesia for elective cesarean section: a comparison between oral single-dose ranitidine, famotidine and omeprazole assessed with fiberoptic gastric aspiration.
    Acta anaesthesiologica Sinica, 1996, Volume: 34, Issue:4

    Topics: Administration, Oral; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anti-Ulcer Agents; Cesarean Section; Double-Blind Method; Famotidine; Female; Humans; Omeprazole; Pneumonia, Aspiration; Pregnancy; Ranitidine

1996
Quadruple therapy: the golden bullet or a drug too far?
    Helicobacter, 1996, Volume: 1, Issue:2

    Topics: Antacids; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Patient Dropouts; Peptic Ulcer; Proton Pump Inhibitors; Research Design; Tetracycline; Time Factors; Treatment Outcome

1996
Effect of gastric acid suppressants on human gastric motility.
    Gut, 1998, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Anti-Ulcer Agents; Cross-Over Studies; Electromyography; Famotidine; Female; Gastric Acid; Gastric Emptying; Gastrointestinal Motility; Histamine H2 Antagonists; Humans; Male; Manometry; Omeprazole; Postprandial Period; Radionuclide Imaging; Ranitidine; Stomach

1998
Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:6

    Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Capsules; Cross-Over Studies; Drug Administration Schedule; Famotidine; Fasting; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Ranitidine; Solubility; Tablets; Time Factors

1997
Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis?
    Journal of gastroenterology, 1999, Volume: 34, Issue:4

    Topics: Alcohol Drinking; Case-Control Studies; Endoscopy, Digestive System; Enzyme Inhibitors; Esophagitis, Peptic; Famotidine; Female; Follow-Up Studies; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Treatment Outcome

1999
The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    The Journal of pharmacy and pharmacology, 1999, Volume: 51, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Multivariate Analysis; Nizatidine; Omeprazole; Patient Dropouts; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Treatment Outcome

1999
On demand therapy of reflux oesophagitis--a prospective study of symptoms, patient satisfaction and quality of life.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Esophagitis, Peptic; Famotidine; Female; Gastric Acidity Determination; Heartburn; Humans; Male; Middle Aged; Norway; Omeprazole; Patient Satisfaction; Prospective Studies; Quality of Life; Ranitidine; Socioeconomic Factors

1999
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resistance, Microbial; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Stomach Ulcer

1999
Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Chronic Disease; Colonic Diseases, Functional; Diarrhea; Eating; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine

1999
Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Pentagastrin; Proton Pump Inhibitors; Sulfoxides; Zollinger-Ellison Syndrome

1999
Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Double-Blind Method; Endosonography; Enzyme Inhibitors; Esophagitis, Peptic; Esophagus; Famotidine; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Mucous Membrane; Muscle, Smooth; Omeprazole; Proton Pump Inhibitors

2000
[Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)].
    Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Double-Blind Method; Drug Resistance; Enzyme Inhibitors; Esophagitis, Peptic; Famotidine; Histamine H2 Antagonists; Humans; Lansoprazole; Long-Term Care; Omeprazole; Proton Pump Inhibitors

2000
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:10

    Topics: Anti-Ulcer Agents; Enzyme Inhibitors; Famotidine; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Neutrophil Infiltration; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Pyloric Antrum; Stomach

2000
Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection.
    European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Tinidazole

2001
[Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring].
    Voenno-meditsinskii zhurnal, 2001, Volume: 322, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Famotidine; Gastric Juice; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Middle Aged; Monitoring, Physiologic; Omeprazole; Rabeprazole

2001
Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:3

    Topics: Adult; Aged; Anti-Ulcer Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Famotidine; Female; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Nonprescription Drugs; Omeprazole

2002
Effects of omeprazole and famotidine on fibroblast growth factor-2 during artificial gastric ulcer healing in humans.
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:4

    Topics: Aged; Anti-Ulcer Agents; Endoscopy; Famotidine; Female; Fibroblast Growth Factor 2; Humans; Male; Middle Aged; Omeprazole; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome; Wound Healing

2002
Randomized comparative study of omeprazole and famotidine in reflux esophagitis.
    Journal of gastroenterology and hepatology, 2002, Volume: 17, Issue:9

    Topics: Aged; Drug Evaluation; Enzyme Inhibitors; Esophagitis, Peptic; Esophagoscopy; Famotidine; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Random Allocation; Treatment Outcome

2002
[Acid-base blood balance in patients with ulcer under treatment by the gastric secretion inhibitors and antacids].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2002, Issue:4

    Topics: Acid-Base Equilibrium; Adolescent; Adult; Aluminum Compounds; Antacids; Duodenal Ulcer; Famotidine; Gastric Juice; Gastric Mucosa; Humans; Male; Omeprazole; Phosphates

2002
Influence of lansoprazole, famotidine, roxatidine and rebamipide administration on the urea breath test for the diagnosis of Helicobacter pylori infection.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Alanine; Anti-Ulcer Agents; Breath Tests; False Negative Reactions; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Piperidines; Predictive Value of Tests; Quinolones; Urea

2003
Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Archives of internal medicine, 2003, Sep-22, Volume: 163, Issue:17

    Topics: Adult; Aged; Antacids; Anti-Ulcer Agents; Breath Tests; Carbolines; Clarithromycin; Drug Therapy, Combination; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Prospective Studies; Secondary Prevention; Treatment Outcome

2003
The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
    Journal of gastroenterology, 2004, Volume: 39, Issue:1

    Topics: Adult; Anti-Ulcer Agents; Cross-Over Studies; Double-Blind Method; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Omeprazole

2004
[Effect of H2-blockers and proton pump inhibitors on intragastric acidity and intraesophageal pH in patients with gastroesophageal reflux disease].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2004, Issue:4

    Topics: Drug Administration Schedule; Endoscopy, Digestive System; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastric Juice; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Omeprazole; Proton Pump Inhibitors; Treatment Outcome

2004
Impact of stress ulcer prophylaxis algorithm study.
    The Annals of pharmacotherapy, 2005, Volume: 39, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Algorithms; Anti-Ulcer Agents; Drug Administration Schedule; Famotidine; Female; Humans; Intensive Care Units; International Normalized Ratio; Male; Middle Aged; Omeprazole; Peptic Ulcer; Risk Factors

2005
Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes.
    Clinical pharmacology and therapeutics, 2005, Volume: 77, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Circadian Rhythm; Cytochrome P-450 CYP2C19; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Female; Gastric Acid; Genotype; Histamine H2 Antagonists; Humans; Male; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton-Translocating ATPases; Rabeprazole

2005
Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Alimentary pharmacology & therapeutics, 2005, Volume: 21 Suppl 2

    Topics: Analysis of Variance; Anti-Ulcer Agents; Drug Therapy, Combination; Famotidine; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Surveys and Questionnaires; Treatment Outcome

2005
Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Alimentary pharmacology & therapeutics, 2005, Volume: 21 Suppl 2

    Topics: Anti-Ulcer Agents; Famotidine; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Hernia, Hiatal; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Quality of Life; Surveys and Questionnaires; Treatment Outcome

2005
Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Alimentary pharmacology & therapeutics, 2005, Volume: 21 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Famotidine; Female; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome

2005
Effect of famotidine on recurrent bleeding after successful endoscopic treatment of bleeding peptic ulcer.
    Alimentary pharmacology & therapeutics, 2005, Volume: 21 Suppl 2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antacids; Anti-Ulcer Agents; Blood Transfusion; Endoscopy, Gastrointestinal; Famotidine; Female; Hemostasis, Endoscopic; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Secondary Prevention; Treatment Outcome

2005
A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
    Alimentary pharmacology & therapeutics, 2005, Volume: 21 Suppl 2

    Topics: Aged; Anti-Ulcer Agents; Cost-Benefit Analysis; Endoscopy, Gastrointestinal; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Male; Omeprazole; Postoperative Hemorrhage; Prospective Studies; Stomach Neoplasms; Stomach Ulcer

2005
Effect of concomitant dosing of famotidine with lansoprazole on gastric acid secretion in relation to CYP2C19 genotype status.
    Alimentary pharmacology & therapeutics, 2005, Jul-01, Volume: 22, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Famotidine; Female; Gastric Acid; Genotype; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Mixed Function Oxygenases; Omeprazole

2005
Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2005, Volume: 37, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Comorbidity; Cross-Over Studies; Drug Tolerance; Famotidine; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Middle Aged; Omeprazole; Pain Measurement; Prospective Studies; Proton Pump Inhibitors

2005
Management of symptoms in step-down therapy of gastroesophageal reflux disease.
    Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Deglutition Disorders; Endosonography; Enzyme Inhibitors; Esophagitis, Peptic; Famotidine; Female; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quality of Life; Recurrence; Treatment Outcome

2005
The effect of rabeprazole alone or in combination with H2 receptor blocker on intragastric pH: a pilot study.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2004, Volume: 15, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Famotidine; Female; Follow-Up Studies; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pilot Projects; Proton Pump Inhibitors; Rabeprazole; Stomach; Treatment Outcome

2004
Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
    Alimentary pharmacology & therapeutics, 2006, Sep-01, Volume: 24, Issue:5

    Topics: Anti-Ulcer Agents; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Iatrogenic Disease; Male; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms; Stomach Ulcer; Treatment Outcome

2006
Initial 48-hour acid inhibition by intravenous infusion of omeprazole, famotidine, or both in relation to cytochrome P450 2C19 genotype status.
    Clinical pharmacology and therapeutics, 2006, Volume: 80, Issue:5

    Topics: Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastric Acidity Determination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Mixed Function Oxygenases; Omeprazole; Single-Blind Method; Time Factors

2006
Which has superior acid-suppressive effect, 10 mg omeprazole once daily or 20 mg famotidine twice daily? Effects of single or repeated administration in Japanese Helicobacter pylori-negative CYP2C19 extensive metabolizers.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:2

    Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Asian People; Circadian Rhythm; Cross-Over Studies; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Genotype; Helicobacter pylori; Humans; Mixed Function Oxygenases; Omeprazole; Prospective Studies; Reference Values; Time Factors; Treatment Outcome

2007
Can famotidine and omeprazole be combined on a once-daily basis?
    Scandinavian journal of gastroenterology, 2007, Volume: 42, Issue:6

    Topics: Adult; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Famotidine; Humans; Omeprazole

2007
Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.
    Journal of gastroenterology, 2009, Volume: 44, Issue:4

    Topics: Adult; Aged; Anti-Ulcer Agents; Esophagitis, Peptic; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Severity of Illness Index; Surveys and Questionnaires; Young Adult

2009
Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2012, Volume: 24, Issue:2

    Topics: Chemotherapy, Adjuvant; Enzyme Inhibitors; Famotidine; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Histamine H2 Antagonists; Humans; Injections; Length of Stay; Male; Omeprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Secondary Prevention

2012
Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:9

    Topics: Adenocarcinoma; Adenoma; Aged; Aged, 80 and over; Analysis of Variance; Famotidine; Female; Gastric Mucosa; Gastroscopy; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Postoperative Hemorrhage; Proton Pump Inhibitors; Single-Blind Method; Statistics, Nonparametric; Stomach Neoplasms; Stomach Ulcer; Wound Healing

2012
Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS).
    BMC gastroenterology, 2012, May-01, Volume: 12

    Topics: Algorithms; Benzamides; Diterpenes; Dose-Response Relationship, Drug; Dyspepsia; Famotidine; Gastroesophageal Reflux; Guideline Adherence; Humans; Japan; Morpholines; Omeprazole; Proton Pump Inhibitors; Treatment Outcome; Upper Gastrointestinal Tract

2012
Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes: a prospective, randomized, multicenter study.
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:11

    Topics: Acute Coronary Syndrome; Aged; Anti-Ulcer Agents; Aspirin; Blood Platelets; Clopidogrel; Drug Antagonism; Famotidine; Female; Humans; Male; Middle Aged; Myocardial Infarction; Omeprazole; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine

2012
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
    Current pharmaceutical design, 2013, Volume: 19, Issue:1

    Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine

2013
Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study.
    Clinical cardiology, 2013, Volume: 36, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Aspirin; Chi-Square Distribution; Clopidogrel; Cross-Over Studies; Drug Interactions; Drug Resistance; Drug Therapy, Combination; Famotidine; Female; Histamine H2 Antagonists; Humans; Israel; Linear Models; Male; Middle Aged; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method; Ticlopidine; Time Factors; Treatment Outcome

2013
Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:6

    Topics: Acetamides; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Famotidine; Female; Humans; Male; Medication Adherence; Middle Aged; Omeprazole; Piperidines; Pyridines; Republic of Korea; Severity of Illness Index; Treatment Outcome

2015
Evaluation of the effect of orally administered acid suppressants on intragastric pH in cats.
    Journal of veterinary internal medicine, 2015, Volume: 29, Issue:1

    Topics: Animals; Antacids; Anti-Ulcer Agents; Area Under Curve; Cats; Cross-Over Studies; Famotidine; Half-Life; Hydrogen-Ion Concentration; Monitoring, Physiologic; Ointments; Omeprazole; Stomach; Tablets

2015
Pharmacokinetic Interaction Study Between Saxagliptin and Omeprazole, Famotidine, or Magnesium and Aluminum Hydroxides Plus Simethicone in Healthy Subjects: An Open-Label Randomized Crossover Study.
    Clinical pharmacology in drug development, 2019, Volume: 8, Issue:4

    Topics: Adamantane; Adult; Aluminum Hydroxide; Area Under Curve; Cross-Over Studies; Dipeptides; Drug Combinations; Drug Interactions; Famotidine; Female; Healthy Volunteers; Humans; Magnesium Hydroxide; Male; Metabolic Clearance Rate; Omeprazole; Simethicone; Young Adult

2019
The Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy Subjects.
    Clinical pharmacology in drug development, 2019, Volume: 8, Issue:5

    Topics: Administration, Oral; Adult; Biological Availability; Famotidine; Female; Food-Drug Interactions; Healthy Volunteers; Humans; Janus Kinase 1; Male; Middle Aged; Omeprazole; Protein Kinase Inhibitors; Proton Pump Inhibitors; Pyridines; Tablets; Triazoles; Young Adult

2019
Omeprazole vs famotidine for the prevention of gastroduodenal injury in high-risk users of low-dose aspirin: A randomized controlled trial.
    Journal of the Chinese Medical Association : JCMA, 2021, Jan-01, Volume: 84, Issue:1

    Topics: Aged; Aged, 80 and over; Aspirin; Famotidine; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Risk Factors

2021
A prospective, randomized, placebo-controlled, double-blinded clinical trial comparing the incidence and severity of gastrointestinal adverse events in dogs with cancer treated with piroxicam alone or in combination with omeprazole or famotidine.
    Journal of the American Veterinary Medical Association, 2021, Aug-15, Volume: 259, Issue:4

    Topics: Animals; Dog Diseases; Dogs; Famotidine; Incidence; Neoplasms; Omeprazole; Piroxicam; Prospective Studies

2021

Other Studies

112 other study(ies) available for omeprazole and famotidine

ArticleYear
[Clinico-pharmacological evaluation of omeprazole, as a proton pump inhibitor, compared with H2-blockers].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:1

    Topics: Adenosine Triphosphatases; Adult; Biological Availability; Drug Tolerance; Famotidine; Gastric Acid; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Humans; Male; Omeprazole; Pepsin A; Tetragastrin

1992
Effects of histamine H2-receptor antagonists and a proton pump inhibitor on the mucosal hydroxyproline content of ethanol-HCl-induced gastric lesions in rats.
    Digestion, 1992, Volume: 51, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Collagen; Ethanol; Famotidine; Gastric Mucosa; Hydrochloric Acid; Hydroxyproline; Male; Omeprazole; Rabeprazole; Rats; Rats, Inbred Strains; Stomach Ulcer

1992
Further evidence for an interaction between alcohol and certain H2-receptor antagonists.
    Alcoholism, clinical and experimental research, 1991, Volume: 15, Issue:6

    Topics: Adult; Alcoholic Intoxication; Cimetidine; Ethanol; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole; Ranitidine

1991
Medical therapy for gastroesophageal reflux disease. Not all treatments are equal!
    Archives of internal medicine, 1991, Volume: 151, Issue:12

    Topics: Drug Administration Schedule; Famotidine; Gastroesophageal Reflux; Humans; Omeprazole

1991
The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
    Life sciences, 1991, Volume: 49, Issue:14

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Dogs; Famotidine; Gastric Acid; Gastric Fistula; Gastric Mucosa; Male; Omeprazole; Pantoprazole; Pentagastrin; Stomach; Sulfoxides

1991
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
    Japanese journal of pharmacology, 1991, Volume: 55, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol Compounds; Dogs; Famotidine; Female; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Pentagastrin; Peptones; Pylorus; Rats; Rats, Inbred Strains

1991
Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
    Japanese journal of pharmacology, 1991, Volume: 55, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Duodenal Ulcer; Duodenum; Esophagitis, Peptic; Famotidine; Gastric Mucosa; Immersion; Lansoprazole; Omeprazole; Peptic Ulcer; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Psychological

1991
Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.
    Gastroenterologia Japonica, 1991, Volume: 26, Issue:2

    Topics: Adult; Aged; Chronic Disease; Cisapride; Esophagitis, Peptic; Esophagus; Famotidine; Female; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Omeprazole; Piperidines; Serotonin Antagonists; Stomach

1991
Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro.
    Journal of hepatology, 1989, Volume: 8, Issue:1

    Topics: Animals; Cell Division; Cells, Cultured; Cimetidine; DNA; Famotidine; Hepatectomy; Histamine H2 Antagonists; Hormones; Liver; Omeprazole; Osmolar Concentration; Ranitidine; Rats; Rats, Inbred F344; Thiazoles

1989
Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
    The Journal of pharmacology and experimental therapeutics, 1989, Volume: 249, Issue:1

    Topics: Animals; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastrins; Histamine H2 Antagonists; Male; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains; Thiazoles

1989
Is there a fundic factor which regulates G cells in the antrum?
    The Journal of surgical research, 1989, Volume: 47, Issue:1

    Topics: Animals; Dose-Response Relationship, Drug; Famotidine; Gastric Fundus; Gastrins; Male; Omeprazole; Pyloric Antrum; Radioimmunoassay; Rats; Rats, Inbred Strains; Thiazoles

1989
[Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1988, Volume: 92, Issue:2

    Topics: Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Depression, Chemical; Famotidine; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; In Vitro Techniques; Male; Omeprazole; Rabbits; Thiazoles

1988
Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
    The Journal of pharmacology and experimental therapeutics, 1985, Volume: 233, Issue:1

    Topics: Animals; Benzimidazoles; Cimetidine; Famotidine; Gastric Emptying; Gastric Juice; Histamine H2 Antagonists; Male; Omeprazole; Rats; Secretory Rate; Thiadiazoles; Thiazoles

1985
[Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1988, Volume: 92, Issue:1

    Topics: Animals; Dogs; Duodenitis; Famotidine; Female; Gastric Acid; Histamine H2 Antagonists; Male; Omeprazole; Rats; Rats, Inbred Strains; Sodium-Potassium-Exchanging ATPase; Stomach Ulcer; Thiazoles

1988
[New developments in ulcer therapy: famotidine, omeprazole misoprostol].
    Medizinische Klinik (Munich, Germany : 1983), 1986, Mar-18, Volume: 81, Issue:6

    Topics: Alprostadil; Anti-Ulcer Agents; Famotidine; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Thiazoles

1986
[Peptic ulcer. New H2 blockers, prostaglandins, benzimidazoles].
    Fortschritte der Medizin, 1987, Apr-10, Volume: 105, Issue:10

    Topics: Alprostadil; Anti-Ulcer Agents; Famotidine; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Thiazoles

1987
[The effects of famotidine and omeprazole on 24-hour intragastric pH of normal subjects].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1988, Volume: 85, Issue:7

    Topics: Adult; Circadian Rhythm; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastric Juice; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Omeprazole; Reference Values; Thiazoles

1988
Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.
    Gut, 1986, Volume: 27, Issue:9

    Topics: Anti-Ulcer Agents; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Famotidine; Gastric Acidity Determination; Humans; Imidazoles; Omeprazole; Ranitidine; Thiazoles

1986
Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression.
    The American journal of physiology, 1995, Volume: 269, Issue:5 Pt 1

    Topics: Animals; Benzodiazepines; Cell Count; Enterochromaffin Cells; Famotidine; Female; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Histidine Decarboxylase; Omeprazole; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Time Factors

1995
Effect of current direction and K+ on polarization of the frog gastric mucosa proton pump.
    Biochimica et biophysica acta, 1995, Nov-22, Volume: 1240, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Anura; Famotidine; Gastric Mucosa; Imidazoles; Membrane Potentials; Omeprazole; Patch-Clamp Techniques; Potassium; Proton Pumps; Thiocyanates

1995
Effects of FK506, an immunosuppressive agent, on genesis of water-immersion stress-induced gastric lesions in rats.
    Digestive diseases and sciences, 1994, Volume: 39, Issue:4

    Topics: Animals; Famotidine; Gastric Mucosa; Immersion; Leukotrienes; Male; Omeprazole; Peroxidase; Polyethylene Glycols; Prostaglandins; Rats; Rats, Wistar; Stomach Ulcer; Stress, Physiological; Superoxide Dismutase; Tacrolimus; Xanthine Oxidase

1994
Outcomes of antireflux therapy for the treatment of chronic laryngitis.
    The Annals of otology, rhinology, and laryngology, 1995, Volume: 104, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Famotidine; Female; Gastroesophageal Reflux; Humans; Laryngitis; Laryngoscopy; Male; Middle Aged; Omeprazole; Prospective Studies; Sleep; Treatment Outcome

1995
Mucosal regeneration of gastric ulcer confirmed by electronic endoscopy.
    Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Electronics, Medical; Famotidine; Female; Gastric Mucosa; Gastroscopy; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Regeneration; Stomach Ulcer

1995
Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
    Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Monitoring, Physiologic; Omeprazole

1995
Drug interactions of H2-receptor antagonists.
    Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 206

    Topics: Adolescent; Adult; Aged; Antacids; Biological Availability; Cimetidine; Drug Interactions; Famotidine; Histamine H2 Antagonists; Humans; Middle Aged; Nizatidine; Omeprazole; Phenytoin; Ranitidine; Theophylline

1994
Peptic ulcer disease in adolescence: changing concepts in the age of Helicobacter pylori.
    The Gastroenterologist, 1994, Volume: 2, Issue:4

    Topics: Adolescent; Adult; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Ranitidine; Recurrence; Sucralfate

1994
Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
    Scandinavian journal of gastroenterology, 1994, Volume: 29, Issue:12

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Nizatidine; Omeprazole; Piperidines; Proton Pump Inhibitors; Stomach Ulcer; Ultrasonography, Interventional; Wound Healing

1994
[Maintenance therapy with antiulcer drugs: review of 71 cases].
    Atencion primaria, 1995, Feb-15, Volume: 15, Issue:2

    Topics: Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Carbonates; Cross-Over Studies; Duodenal Ulcer; Famotidine; Female; Humans; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Risk Factors; Time Factors

1995
Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
    Japanese journal of pharmacology, 1993, Volume: 63, Issue:3

    Topics: Animals; Cimetidine; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Guinea Pigs; Heart Atria; Heart Rate; Histamine; Histamine H2 Antagonists; Infusions, Intravenous; Male; Omeprazole; Pyrimidinones; Rats; Rats, Wistar; Thiazoles

1993
Hyperplastic polyps following treatment of acute gastric ulcers.
    Internal medicine (Tokyo, Japan), 1994, Volume: 33, Issue:6

    Topics: Esophageal and Gastric Varices; Famotidine; Female; Humans; Hyperplasia; Middle Aged; Omeprazole; Polyps; Sclerotherapy; Stomach Neoplasms; Stomach Ulcer

1994
Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo.
    Digestive diseases and sciences, 1994, Volume: 39, Issue:10

    Topics: Animals; Blotting, Western; Cimetidine; Drug Interactions; Famotidine; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Male; Microscopy, Electron; Omeprazole; Parietal Cells, Gastric; Rabbits

1994
YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Benzodiazepines; Duodenal Ulcer; Epirizole; Ethanol; Famotidine; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Indomethacin; Male; Omeprazole; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Stomach Ulcer; Stress, Physiological

1994
Hepatitis following treatments with famotidine and then cimetidine.
    The Annals of pharmacotherapy, 1994, Volume: 28, Issue:1

    Topics: Chemical and Drug Induced Liver Injury; Cimetidine; Duodenal Ulcer; Famotidine; Fatty Liver; Female; Humans; Middle Aged; Omeprazole

1994
[High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of acute upper gastrointestinal hemorrhage in a retrospective comparison].
    Zeitschrift fur Gastroenterologie, 1994, Volume: 32, Issue:2

    Topics: Aged; Aged, 80 and over; Aluminum Hydroxide; Antacids; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Famotidine; Gastrointestinal Hemorrhage; Humans; Magnesium Hydroxide; Omeprazole; Peptic Ulcer Hemorrhage; Pirenzepine; Recurrence; Retrospective Studies; Survival Rate

1994
Comparison of omeprazole and famotidine on esophageal pH in patients with moderate to severe esophagitis: a cross-over study.
    The American journal of gastroenterology, 1994, Volume: 89, Issue:5

    Topics: Adult; Aged; Esophagitis; Esophagus; Famotidine; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole

1994
Role of histamine2 receptor in increased expression of rat gastric H(+)-K(+)-ATPase alpha-subunit induced by omeprazole.
    The American journal of physiology, 1993, Volume: 265, Issue:4 Pt 1

    Topics: Animals; Drug Synergism; Famotidine; H(+)-K(+)-Exchanging ATPase; Male; Omeprazole; Rats; Rats, Wistar; Receptors, Histamine H2; RNA, Messenger; Stomach

1993
The relationship between endoscopic findings of gastric ulcer scar and ulcer relapse.
    Journal of clinical gastroenterology, 1993, Volume: 17 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Famotidine; Female; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Omeprazole; Recurrence; Stomach Ulcer; Wound Healing

1993
Effect of inhibitors of gastric secretion on polarization of gastric potential by voltage clamping.
    The American journal of physiology, 1993, Volume: 264, Issue:4 Pt 1

    Topics: Animals; Famotidine; Gastric Acid; Gastric Mucosa; In Vitro Techniques; Kinetics; Membrane Potentials; Models, Biological; Omeprazole; Potassium; Rana pipiens; Sodium Chloride; Sodium-Potassium-Exchanging ATPase; Stomach

1993
Efficacy of famotidine for omeprazole-refractory gastric ulcer.
    Digestive diseases and sciences, 1993, Volume: 38, Issue:3

    Topics: Adult; Famotidine; Humans; Male; Omeprazole; Stomach Ulcer

1993
Efficacy of long-term therapy with low doses of omeprazole in the control of gastric acid secretion in Zollinger-Ellison syndrome patients.
    Alimentary pharmacology & therapeutics, 1993, Volume: 7, Issue:2

    Topics: Adult; Drug Administration Schedule; Famotidine; Female; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Zollinger-Ellison Syndrome

1993
The liver regenerative response elicited by antisecretory agents in partially hepatectomized rats: a comparison between omeprazole and famotidine.
    Surgery today, 1995, Volume: 25, Issue:9

    Topics: Animals; Anti-Ulcer Agents; Famotidine; Gastrins; Hepatectomy; Kidney Function Tests; Liver Function Tests; Liver Regeneration; Male; Mitotic Index; Omeprazole; Organ Size; Rats; Rats, Wistar

1995
Regulation of peptide YY homeostasis by gastric acid and gastrin.
    Endocrinology, 1996, Volume: 137, Issue:4

    Topics: Animals; Dogs; Famotidine; Female; Gastric Acid; Gastrinoma; Gastrins; Gastrointestinal Hormones; Gene Expression; Homeostasis; Humans; Male; Mice; Mice, Nude; Omeprazole; Peptide YY; Peptides; Rats; Rats, Sprague-Dawley; RNA, Messenger

1996
Capsaicin-sensitive sensory neurons are involved in bicarbonate secretion induced by lansoprazole, a proton pump inhibitor, in rats.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bicarbonates; Capsaicin; Duodenum; Famotidine; Histamine H2 Antagonists; Intestinal Mucosa; Lansoprazole; Male; Neurons, Afferent; Omeprazole; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Stimulation, Chemical; Vasoactive Intestinal Peptide

1996
The effects of acid inhibitors on gastric mucus.
    Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:4

    Topics: Famotidine; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Humans; Omeprazole

1996
The effects of omeprazole and famotidine on mucin and PGE2 release in the rat stomach.
    Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Dinoprostone; Enzyme Inhibitors; Famotidine; Gastric Mucins; Glycoproteins; Histamine H2 Antagonists; Male; Omeprazole; Parietal Cells, Gastric; Rats; Rats, Wistar

1996
[Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 108, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Famotidine; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Indomethacin; Lansoprazole; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley

1996
[Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1996, Volume: 108, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Animals; Anti-Ulcer Agents; Famotidine; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Injections, Intravenous; Lansoprazole; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stress, Physiological

1996
Evaluation of somatostatin analogues for the detection and treatment of gastrinoma in a dog.
    The Journal of small animal practice, 1997, Volume: 38, Issue:7

    Topics: Animals; Anti-Ulcer Agents; Antineoplastic Agents, Hormonal; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Famotidine; Female; Gastrinoma; Gastrins; Immunohistochemistry; Indium Radioisotopes; Injections, Subcutaneous; Microscopy, Electron; Octreotide; Omeprazole; Pancreas; Pancreatic Neoplasms; Radioimmunoassay; Radionuclide Imaging; Receptors, Somatostatin; Somatostatin; Sucralfate

1997
Effects of cimetidine on acute gastric mucosal injury induced by ischemia-reperfusion in rats.
    Pharmacology, 1997, Volume: 55, Issue:3

    Topics: Animals; Anti-Ulcer Agents; Cimetidine; Erythrocyte Membrane; Famotidine; Gastric Mucosa; Histamine H2 Antagonists; Lipid Peroxidation; Male; Omeprazole; Rats; Rats, Wistar; Reperfusion Injury; Stomach Diseases

1997
H2-receptor antagonist reduces food intake and weight gain in rats by non-gastric acid secretory mechanisms.
    Acta physiologica Scandinavica, 1997, Volume: 161, Issue:4

    Topics: Animals; Anti-Ulcer Agents; Cimetidine; Eating; Famotidine; Gastric Acid; Histamine H2 Antagonists; Male; Omeprazole; Ranitidine; Rats; Rats, Wistar; Weight Gain

1997
Enhancement of neutrophil infiltration in the corpus after failure of Helicobacter pylori eradication.
    Journal of clinical gastroenterology, 1997, Volume: 25 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Lansoprazole; Male; Middle Aged; Neutrophils; Omeprazole; Peroxidase; Proton Pump Inhibitors; Stomach Ulcer

1997
Human gastric carcinoid detected during long-term antiulcer therapy of H2 receptor antagonist and proton pump inhibitor.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Carcinoid Tumor; Famotidine; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Stomach Neoplasms; Time Factors

1998
Omeprazole, nitrendipine, famotidine and stress-induced ulcers.
    Italian journal of gastroenterology and hepatology, 1997, Volume: 29, Issue:2

    Topics: Animals; Anti-Ulcer Agents; Calcium Channel Blockers; Famotidine; Gastric Mucosa; Histamine H2 Antagonists; Male; Nitrendipine; Omeprazole; Rats; Rats, Wistar; Stomach Ulcer; Stress, Physiological

1997
Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
    Clinical pharmacology and therapeutics, 1998, Volume: 64, Issue:5

    Topics: Administration, Oral; Anti-Ulcer Agents; Cimetidine; Cost-Benefit Analysis; Drug Utilization; Famotidine; Feedback; Hong Kong; Hospitals, Teaching; Humans; Infusions, Intravenous; Medical Audit; Nizatidine; Omeprazole; Practice Patterns, Physicians'; Ranitidine

1998
Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
    Japanese journal of pharmacology, 1998, Volume: 78, Issue:3

    Topics: Aminopyrine; Animals; Anti-Ulcer Agents; Bucladesine; Carbachol; Carbon Radioisotopes; Cholinergic Agonists; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Omeprazole; Pentagastrin; Pirenzepine; Ranitidine; Sulfones

1998
Prostacyclin analog prevents stress-induced expression of immediate early genes and gastric mucosal lesions in the rat stomach.
    Life sciences, 1999, Volume: 64, Issue:21

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Epoprostenol; Famotidine; Gastric Mucosa; Genes, Immediate-Early; Lansoprazole; Male; Omeprazole; Rats; Rats, Wistar; Regional Blood Flow; Stress, Physiological

1999
Helicobacter pylori infection and persistent hyperemesis gravidarum.
    American journal of perinatology, 1999, Volume: 16, Issue:2

    Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hyperemesis Gravidarum; Omeprazole; Penicillins; Peptic Ulcer; Pregnancy; Pregnancy Complications, Infectious; Proton Pump Inhibitors; Ranitidine

1999
Optimum management of mild esophagitis in Japan.
    Journal of gastroenterology, 1999, Volume: 34, Issue:4

    Topics: Anti-Ulcer Agents; Disease Management; Esophagitis, Peptic; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Japan; Omeprazole; Proton Pump Inhibitors

1999
[Role of 24 hour intraesophageal pH monitoring in diagnosis of gastroesophageal reflux and assessment of drug effectiveness].
    Klinicheskaia meditsina, 1999, Volume: 77, Issue:7

    Topics: Adult; Anti-Ulcer Agents; Circadian Rhythm; Esophagus; Famotidine; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Retrospective Studies; Severity of Illness Index; Treatment Outcome

1999
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:1

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Tinidazole

2000
A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14 Suppl 1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Cell Adhesion Molecules; Cell Communication; Cell Culture Techniques; Endothelium; Enzyme Inhibitors; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Neutrophils; Omeprazole; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer

2000
Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.
    Digestive diseases and sciences, 2001, Volume: 46, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Aspirin; Disease Models, Animal; Drug Evaluation, Preclinical; Famotidine; Female; Free Radical Scavengers; Gastric Acidity Determination; Lipid Peroxidation; Male; Melatonin; Omeprazole; Rats; Stomach Ulcer

2001
[Relations of acid-base balance and gastric secretion of hydrogen carbonate ions in patients with peptic ulcer].
    Terapevticheskii arkhiv, 2001, Volume: 73, Issue:2

    Topics: Acid-Base Equilibrium; Acidosis; Adult; Anti-Ulcer Agents; Bicarbonates; Famotidine; Female; Gastric Acid; Gastric Juice; Humans; Male; Omeprazole; Peptic Ulcer; Time Factors

2001
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
    Inflammatory bowel diseases, 2001, Volume: 7, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretation, Statistical; Disaccharides; Duodenal Diseases; Esophageal Diseases; Famotidine; Female; Humans; Lansoprazole; Male; Mannitol; Mesalamine; Middle Aged; Omeprazole; Permeability; Proton Pumps; Retrospective Studies; Stomach Diseases; Treatment Outcome

2001
Antiulcerogenic effect of Hippophae rhamnoides L.
    Phytotherapy research : PTR, 2001, Volume: 15, Issue:7

    Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Famotidine; Fruit; Indomethacin; Male; Misoprostol; Omeprazole; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Rosales; Stomach Ulcer; Stress, Physiological

2001
Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Circadian Rhythm; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Heterozygote; Homozygote; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Omeprazole; Proton Pump Inhibitors

2002
Wine stimulates gastric acid secretion in isolated rabbit gastric glands via two different pathways.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16 Suppl 2

    Topics: Animals; Calcium; Chelating Agents; Egtazic Acid; Enzyme Inhibitors; Ethanol; Famotidine; Female; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; In Vitro Techniques; Omeprazole; Rabbits; Wine

2002
[Treatment of NSAIDs induced ulcers].
    Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Famotidine; Female; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Misoprostol; Omeprazole; Retrospective Studies; Stomach Ulcer; Treatment Outcome

2002
[The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2002, Issue:2

    Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Famotidine; Female; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Male; Middle Aged; Mucins; Muscarinic Antagonists; Omeprazole; Pirenzepine; Proton Pump Inhibitors; Ranitidine; Receptor, Muscarinic M1; Receptors, Muscarinic; Stomach Ulcer

2002
Primary hyperparathyroidism with duodenal ulcer and H. pylori infection.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Aged; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Famotidine; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Hyperparathyroidism; Male; Omeprazole; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Rabeprazole

2002
[Effect of various antisecretory drugs on morphological changes in rat gastric mucosa in experimental stomach ulcers].
    Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2002, Volume: 48, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Epithelium; Famotidine; Gastric Mucosa; Lansoprazole; Male; Microcirculation; Octreotide; Omeprazole; Rats; Rats, Wistar; Stomach Ulcer; Treatment Outcome

2002
Efficacy of a 1-week course of proton-pump inhibitor-based triple therapy for eradicating Helicobacter pylori in patients with and without chronic renal failure.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:3

    Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome

2002
Drug interaction of tacrolimus and proton pump inhibitors in renal transplant recipients with CYP2C19 gene mutation.
    Transplantation proceedings, 2002, Volume: 34, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cytochrome P-450 CYP2C19; Drug Interactions; Famotidine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lansoprazole; Male; Middle Aged; Mixed Function Oxygenases; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Tacrolimus

2002
Is an intravenous histamine H2 receptor antagonist superior to an intravenous proton pump inhibitor in acid suppression?
    Journal of gastroenterology, 2004, Volume: 39, Issue:1

    Topics: Anti-Ulcer Agents; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Injections, Intravenous; Omeprazole; Proton Pump Inhibitors

2004
Omeprazole is more effective than famotidine for preventing acute gastritis in rats.
    Surgery today, 2004, Volume: 34, Issue:8

    Topics: Animals; Anti-Ulcer Agents; Cell Count; Famotidine; Gastric Acid; Gastric Mucosa; Gastritis; Hydrogen-Ion Concentration; Male; Mast Cells; Omeprazole; Premedication; Rats; Rats, Wistar; Stomach Ulcer; Stress, Physiological

2004
Effects of omeprazole, famotidine, and ranitidine on the enzyme activities of carbonic anhydrase from bovine stomach in vitro and rat erythrocytes in vivo.
    Biological & pharmaceutical bulletin, 2004, Volume: 27, Issue:11

    Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cattle; Erythrocytes; Esterases; Famotidine; In Vitro Techniques; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach

2004
[Problems of excretory insufficiency of the pancreas].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2004, Issue:4

    Topics: Adolescent; Adult; Aged; Famotidine; Feces; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pain; Pancreas; Pancreatic Elastase; Pancreatic Function Tests; Pancreatitis; Treatment Outcome

2004
Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?
    Journal of gastroenterology, 2005, Volume: 40, Issue:2

    Topics: Adult; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Famotidine; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Omeprazole

2005
Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
    American journal of veterinary research, 2005, Volume: 66, Issue:3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Animals; Benzimidazoles; Dogs; Dose-Response Relationship, Drug; Famotidine; Food Deprivation; Gastric Acidity Determination; Gastric Juice; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Reference Values; Sulfoxides

2005
Attenuation of acid induced oesophagitis in VR-1 deficient mice.
    Gut, 2006, Volume: 55, Issue:1

    Topics: Acute Disease; Animals; Anti-Ulcer Agents; Capsaicin; Endocytosis; Esophagitis; Famotidine; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Confocal; Omeprazole; Peroxidase; Receptors, Neurokinin-1; Severity of Illness Index; TRPV Cation Channels

2006
[Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Khirurgiia, 2005, Issue:8

    Topics: Acute Disease; Anti-Ulcer Agents; Famotidine; Gastrointestinal Agents; Histamine H2 Antagonists; Humans; Octreotide; Omeprazole; Peptic Ulcer; Peptic Ulcer Hemorrhage; Pirenzepine; Proton Pump Inhibitors

2005
The efficacy of preanesthetic proton pump inhibitor treatment for patients on long-term H2 antagonist therapy.
    Anesthesia and analgesia, 2005, Volume: 101, Issue:4

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Drug Tolerance; Famotidine; Female; Gastric Acidity Determination; Gastrins; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Piperidines; Pneumonia, Aspiration; Preanesthetic Medication; Proton Pump Inhibitors; Rabeprazole

2005
A novel gastric lesion model induced in rats by partial gastric vascular ligation.
    Inflammopharmacology, 2005, Volume: 13, Issue:1-3

    Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Ligation; Male; Omeprazole; Rats; Rats, Wistar; Stomach Diseases; Time Factors

2005
[Complex evaluation of the action of inhibitors of hydrochloric acid secretion on gastric function in ulcer disease].
    Terapevticheskii arkhiv, 2006, Volume: 78, Issue:2

    Topics: Adult; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Famotidine; Follow-Up Studies; Gastric Acid; Gastric Emptying; Gastric Mucosa; Humans; Male; Middle Aged; Omeprazole; Stomach; Treatment Outcome

2006
Effects of rabeprazole or famotidine during cardiac surgery on perioperative gastric and esophageal pH readings.
    The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi, 2006, Volume: 54, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cardiac Surgical Procedures; Combined Modality Therapy; Esophagus; Famotidine; Female; Gastric Acid; Gastrointestinal Hemorrhage; Heart Diseases; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Perioperative Care; Rabeprazole; Stomach; Time Factors; Treatment Outcome

2006
Expression of HSP72 in the gastric mucosa is regulated by gastric acid in rats-correlation of HSP72 expression with mucosal protection.
    Biochemical and biophysical research communications, 2006, Oct-20, Volume: 349, Issue:2

    Topics: Animals; Anti-Ulcer Agents; Carnosine; Famotidine; Gastric Acid; Gastric Mucosa; Gene Expression Regulation; HSP72 Heat-Shock Proteins; Hydrochloric Acid; Hydrogen-Ion Concentration; Male; Mucous Membrane; Omeprazole; Organometallic Compounds; Rats; Rats, Sprague-Dawley; Zinc Compounds; Zinc Sulfate

2006
Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Alimentary pharmacology & therapeutics, 2007, Jan-01, Volume: 25, Issue:1

    Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Epidemiologic Methods; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors

2007
Promotion of cutaneous wound healing by famotidine in Wistar rats.
    The Indian journal of medical research, 2007, Volume: 125, Issue:2

    Topics: Analysis of Variance; Animals; Collagen; Famotidine; Granulation Tissue; Omeprazole; Rats; Rats, Wistar; Skin; Sucralfate; Wound Healing

2007
[Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Famotidine; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Organometallic Compounds; Peptic Ulcer; Rabeprazole; Ranitidine; Russia

2007
[Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
    Khirurgiia, 2009, Issue:3

    Topics: Antacids; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Pirenzepine; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors

2009
Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
    Journal of gastroenterology and hepatology, 2010, Volume: 25 Suppl 1

    Topics: 16,16-Dimethylprostaglandin E2; Acetamides; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Capsaicin; Cimetidine; Disease Models, Animal; Enterobacteriaceae; Famotidine; Histamine H2 Antagonists; Intestinal Mucosa; Intestine, Small; Male; Mucin-2; Nitric Oxide Synthase Type II; Omeprazole; Peptic Ulcer; Peroxidase; Phenylpropionates; Piperidines; Proton Pump Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sensory Receptor Cells

2010
[Hypomagnesemia related to the use of omeprazole with negative result for mutation in the TRPM6 gene].
    Medicina clinica, 2011, Jul-09, Volume: 137, Issue:4

    Topics: Aged; Alcoholism; Esophagitis, Peptic; Famotidine; Histamine H2 Antagonists; Humans; Intestinal Absorption; Magnesium; Magnesium Deficiency; Male; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Tetany; TRPM Cation Channels

2011
Intermittent use of pantoprazole and famotidine in severe hypomagnesaemia due to omeprazole.
    The Netherlands journal of medicine, 2010, Volume: 68, Issue:10

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Ulcer Agents; Famotidine; Histamine H2 Antagonists; Humans; Magnesium Deficiency; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Treatment Outcome

2010
Inhibitors of acid secretion can benefit gastric wound repair independent of luminal pH effects on the site of damage.
    Gut, 2012, Volume: 61, Issue:6

    Topics: Animals; Epithelium; Famotidine; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Hydrogen-Ion Concentration; Male; Mice; Mice, Inbred C57BL; Omeprazole; Stomach; Wound Healing

2012
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
    Acta dermato-venereologica, 2012, Volume: 92, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays

2012
The elegance of the gastric mucosal barrier: designed by nature for nature.
    Gut, 2012, Volume: 61, Issue:6

    Topics: Animals; Famotidine; Female; Gastric Acid; Male; Omeprazole; Stomach; Wound Healing

2012
A new model of gastric bleeding induced in rats by aspirin plus clopidogrel under stimulation of acid secretion. Prophylactic effects of antiulcer drugs.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2012, Volume: 63, Issue:1

    Topics: Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Drug Interactions; Famotidine; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Male; Omeprazole; Peroxidase; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Ticlopidine

2012
Gastric acid inhibitors may prevent/heal oxyntic lesions by reducing blood demand.
    Gut, 2013, Volume: 62, Issue:1

    Topics: Animals; Famotidine; Female; Gastric Acid; Male; Omeprazole; Stomach; Wound Healing

2013
Proton-pump inhibitors could be innocent when used concomitantly with clopidogrel.
    Circulation journal : official journal of the Japanese Circulation Society, 2012, Volume: 76, Issue:11

    Topics: Acute Coronary Syndrome; Anti-Ulcer Agents; Aspirin; Blood Platelets; Clopidogrel; Famotidine; Female; Humans; Male; Omeprazole; Platelet Aggregation Inhibitors; Ticlopidine

2012
Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study.
    BioMed research international, 2014, Volume: 2014

    Topics: Aged; Aged, 80 and over; Aspirin; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Thromboembolism

2014
In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
    Gastroenterology, 2021, Volume: 160, Issue:6

    Topics: Biological Transport; Boron Compounds; Calcium; Calcium Channel Blockers; Cell Line; Chemokine CCL26; Diltiazem; Egtazic Acid; Eosinophilic Esophagitis; Epithelial Cells; Esophageal Mucosa; Famotidine; Female; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Humans; Interleukin-4 Receptor alpha Subunit; Male; Omeprazole; Primary Cell Culture; Proton Pump Inhibitors; Proton Pumps; Ranitidine; RNA, Messenger; Signal Transduction; Th2 Cells; Verapamil

2021
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
    Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:5

    Topics: Animals; Famotidine; Gastroesophageal Reflux; Gastrointestinal Neoplasms; Humans; Omeprazole; Ranitidine; United States

2021
Evaluation of a long-acting injectable formulation of omeprazole in healthy dogs.
    Journal of veterinary internal medicine, 2022, Volume: 36, Issue:4

    Topics: Animals; Anti-Ulcer Agents; Cross-Over Studies; Dogs; Famotidine; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Omeprazole; Prospective Studies

2022
Gastrointestinal prophylaxis for COVID-19: an illustration of severe bias arising from inappropriate comparators in observational studies.
    Journal of clinical epidemiology, 2022, Volume: 151

    Topics: COVID-19; Famotidine; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors

2022
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
    European journal of medicinal chemistry, 2009, Volume: 44, Issue:11

    Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013